IN2014MN01800A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01800A
IN2014MN01800A IN1800MUN2014A IN2014MN01800A IN 2014MN01800 A IN2014MN01800 A IN 2014MN01800A IN 1800MUN2014 A IN1800MUN2014 A IN 1800MUN2014A IN 2014MN01800 A IN2014MN01800 A IN 2014MN01800A
Authority
IN
India
Prior art keywords
nanoparticles
methods
interaction
measuring
present
Prior art date
Application number
Inventor
Meike Roskamp
Vanessa Bonnard
Sylviane Boucharens
Original Assignee
Pharmadiagnostics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadiagnostics Nv filed Critical Pharmadiagnostics Nv
Publication of IN2014MN01800A publication Critical patent/IN2014MN01800A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to methods of measuring interaction between a first and a second molecule for example a protein and an antibody by conjugation of one of these molecules with nanoparticles and measuring the interaction between the first and second molecule via changes in the optical properties of the nanoparticles. The present invention further relates to methods of coating nanoparticles.
IN1800MUN2014 2012-02-16 2013-02-15 IN2014MN01800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599455P 2012-02-16 2012-02-16
GBGB1202631.6A GB201202631D0 (en) 2012-02-16 2012-02-16 Method of measuring interaction between molecules
PCT/EP2013/053103 WO2013121011A1 (en) 2012-02-16 2013-02-15 Method and kit for measuring interaction between molecules

Publications (1)

Publication Number Publication Date
IN2014MN01800A true IN2014MN01800A (en) 2015-07-03

Family

ID=45939693

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1800MUN2014 IN2014MN01800A (en) 2012-02-16 2013-02-15

Country Status (9)

Country Link
US (2) US9678066B2 (en)
EP (1) EP2814774A1 (en)
AU (1) AU2013220314B2 (en)
BE (1) BE1020732A5 (en)
CA (1) CA2864614A1 (en)
GB (1) GB201202631D0 (en)
HK (1) HK1203919A1 (en)
IN (1) IN2014MN01800A (en)
WO (1) WO2013121011A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016057474A1 (en) * 2014-10-06 2016-04-14 Indiana University Research & Technology Corporation Systems and methods for localized surface plasmon resonance biosensing
WO2017001374A1 (en) * 2015-06-30 2017-01-05 Imec Vzw Surface immobilization of an analyte-recognizing molecule
CL2017001945A1 (en) * 2017-07-30 2018-10-19 Univ Tecnica Federico Santa Maria Utfsm Method, process, composition and kit to measure concentration of dissolved molecules in the continuous phase of a colloid.
US10758983B1 (en) 2018-04-17 2020-09-01 Government Of The United States, As Represented By The Secretary Of The Air Force Concentrated synthesis of monodispersed gold nanorods
CL2018001473A1 (en) * 2018-06-01 2019-10-25 Univ Tecnica Federico Santa Maria Utfsm Kit and methods to evaluate the adsorbent properties of the surface of a material
WO2020086531A1 (en) 2018-10-22 2020-04-30 Indiana University Research And Technology Corporation Systems and methods for localized surface plasmon resonance biosensing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275310A1 (en) 2004-09-30 2006-12-07 Nano Science Diagnostics, Inc. Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy
US8426152B2 (en) 2007-01-03 2013-04-23 Lamdagen Corporation Enzymatic assay for LSPR
DK2153227T3 (en) 2007-05-29 2011-04-04 Pharma Diagnostics Nv Reagents and Methods for Determining PK / ADME-TOX Properties of New Chemical Compounds and in Drug Candidates
US20120164073A1 (en) 2007-11-30 2012-06-28 Old Dominion University Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles
US20120202218A1 (en) * 2008-09-12 2012-08-09 Modpro Ab Detection method and device based on nanoparticle aggregation
GB201003088D0 (en) 2010-02-24 2010-04-14 Univ Exeter Method for the preparation of a novel nanoparticle conjugate

Also Published As

Publication number Publication date
US9678066B2 (en) 2017-06-13
CA2864614A1 (en) 2013-08-22
AU2013220314A1 (en) 2014-08-14
GB201202631D0 (en) 2012-04-04
US20170248589A1 (en) 2017-08-31
US20150024402A1 (en) 2015-01-22
BE1020732A5 (en) 2014-04-01
AU2013220314B2 (en) 2016-03-10
WO2013121011A1 (en) 2013-08-22
EP2814774A1 (en) 2014-12-24
HK1203919A1 (en) 2015-11-06

Similar Documents

Publication Publication Date Title
NZ799532A (en) Methods and means for the production of ig-like molecules
CY1121862T1 (en) ANTI-PHF-TAU ANTIBODIES AND USES THEREOF
CY1123550T1 (en) DIPLOID EGFR/C-MET ANTIBODIES
AU2017204797B2 (en) Antibodies with modified isoelectric points
CR20130359A (en) CEA ANTIBODIES
SA112330988B1 (en) TROP-2 Antibodies and Their Uses
MX2016008098A (en) Bispecific her2 antibodies and methods of use.
MX360368B (en) Modified antibody regions and uses thereof.
BR112015024553A2 (en) multispecific antibody, isolated antibody, isolated nucleic acid, host cell, antibody production method, immunoconjugate, pharmaceutical formulation, antibody use and method of treating individuals with disorder
EA201490768A1 (en) APPLICATION OF MOLECULES CONNECTING SEMAFORIN-4D TO MODULATE THE PERMEABILITY OF THE HEMATOENECEPHALIC BARRIER
MX2015012122A (en) Antibody drug conjugates and corresponding antibodies.
MX2014015088A (en) Anti-tofacitinib antibodies and uses thereof for drug monitoring.
IN2014MN01800A (en)
ECSP14028523A (en) ANTI-GCC ANTIBODY MOLECULES AND USE THEREOF
UA110470C2 (en) Antidote of anticoagulant
MX342034B (en) Monovalent antigen binding proteins.
EA201590173A1 (en) IMMUNOCONGUTS CONTAINING ANTIBODIES TO CD22
UA118083C2 (en) SELECTED MONOCLONAL ANTIBODY AGAINST THE REFERENCE DIRECTOR (RGMa) MOLECULES AND ITS APPLICATION IN THE TREATMENT OF ROSAIROEYER
BR112014012590A8 (en) ANTI-CD98 ANTIBODIES AND METHODS OF THEIR USE
WO2014100143A3 (en) Liquid antibody formulation with improved aggregation properties
BR112014002140A2 (en) anti-cxcr4 antibody and use for cancer detection and diagnosis
TN2013000388A1 (en) Anticoagulant antidotes
GB2495884A (en) A method of increasing the effect of an activated-potentiated form of an antibody
WO2012060882A3 (en) Interferometric detection using nanoparticles
HK1217960A1 (en) Acceptor framework for cdr grafting